[Extraintestinal manifestations].
Adler
G
G
Abt. Innere Medizin I, Medizinische Universitätsklinik Ulm.
Reinshagen
M
M
D000686:Amyloidosis / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D002760:Cholangiopancreatography, Endoscopic Retrograde; D015209:Cholangitis, Sclerosing / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy; D002769:Cholelithiasis / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy; D015331:Cohort Studies; D018849:Controlled Clinical Trials as Topic; D003424:Crohn Disease / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D003430:Cross-Sectional Studies; D004359:Drug Therapy, Combination; D005128:Eye Diseases / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D007592:Joint Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology*; D007669:Kidney Calculi / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy; D007674:Kidney Diseases / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy; D008107:Liver Diseases / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D008137:Longitudinal Studies; D008171:Lung Diseases / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy; D009422:Nervous System Diseases / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D010024:Osteoporosis / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy; D010195:Pancreatitis / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy; D010919:Placebos; D011446:Prospective Studies; D012189:Retrospective Studies; D012306:Risk; D012307:Risk Factors; D012871:Skin Diseases / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy; D013923:Thromboembolism / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy; D014580:Ursodeoxycholic Acid / Q000008:administration & dosage / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D010919:Placebos; D014580:Ursodeoxycholic Acid